+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urolithiasis Mangement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, Form, Source, End Use, Sales Channel, Geographic Coverage and By Company)

  • PDF Icon

    Report

  • 200 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6052157
The global urolithiasis management devices market is projected to witness steady growth, reaching an estimated valuation of USD 1.75 billion in 2025 and USD 2.40 billion by 2032, expanding at a CAGR of 4.63%. The market’s expansion is driven by rising incidences of kidney stones, advancements in minimally invasive treatment options, and growing demand for effective urolithiasis management solutions.

Market Insights

Urolithiasis management devices play a crucial role in diagnosing, treating, and preventing kidney stones. These medical tools encompass a range of non-invasive and minimally invasive treatment options, including extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL). Increasing awareness regarding the importance of early diagnosis and advanced treatment methods is significantly fueling market growth.

Continuous technological advancements have led to the development of innovative stone management solutions, improving patient outcomes and enabling faster recovery times. The increasing adoption of robotics, laser technology, and advanced imaging methods is further transforming urolithiasis treatment.

Market Growth Drivers

Technological Advancements in Urolithiasis Management

  • The integration of laser technology, robotic surgery, and high-precision imaging has enhanced the efficiency of urolithiasis treatment.
  • Minimally invasive techniques such as ureteroscopy and intracorporeal lithotripsy are gaining traction due to their improved success rates and reduced patient recovery times.

Rising Incidence of Kidney Stones

  • Unhealthy dietary habits, sedentary lifestyles, and dehydration have contributed to the growing prevalence of urolithiasis worldwide.
  • The increasing patient pool is driving the demand for advanced treatment options and management devices.

Growing Preference for Non-invasive Procedures

  • ESWL remains the preferred treatment method due to its non-invasive nature, quick recovery times, and high success rates.
  • Patients and healthcare providers are increasingly adopting less intrusive approaches for kidney stone treatment.

Expansion of Telemedicine in Urolithiasis Management

  • The integration of telehealth platforms with urolithiasis management devices is enhancing remote monitoring and follow-up care.
  • This shift is improving patient access to specialized urological care and driving demand for connected medical devices.

Business Opportunities

Innovation in Smart Urolithiasis Devices

  • The development of AI-powered diagnostics, real-time monitoring tools, and personalized treatment solutions presents growth opportunities.
  • Investments in R&D are expected to drive the introduction of next-generation urolithiasis management devices.

Emerging Markets in Asia-Pacific and Latin America

  • Increasing healthcare expenditure, rising awareness, and improving medical infrastructure in developing nations are opening new revenue streams.
  • Governments and healthcare providers are focusing on upgrading facilities and adopting advanced treatment technologies.

Strategic Collaborations and Mergers

  • Leading companies are forming alliances with research institutions, hospitals, and healthcare providers to expand their market presence.
  • Partnerships aimed at advancing minimally invasive surgical technologies and improving accessibility will further boost market penetration.

Regional Analysis

North America: Leading Market Share

  • The presence of advanced healthcare infrastructure, high prevalence of kidney stone cases, and favorable reimbursement policies makes North America a dominant player in the global market.
  • The region is at the forefront of technological advancements and early adoption of innovative urolithiasis management solutions.

Europe: Strong Market Growth

  • Increasing awareness about kidney stone management and advancements in medical technology contribute to Europe's market expansion.
  • Government initiatives to improve healthcare services are further supporting market development.

Asia-Pacific: Fastest Growing Region

  • Rapid urbanization, changing lifestyles, and rising healthcare investments are driving the market growth in Asia-Pacific.
  • Countries like China, India, and Japan are witnessing increased demand for advanced urolithiasis management devices due to rising patient numbers.

Middle East & Africa, and Latin America: Expanding Market Presence

  • Improving access to specialized medical care and growing investment in healthcare infrastructure are propelling market expansion in these regions.
  • Increasing awareness campaigns regarding kidney stone prevention and treatment are contributing to the market's steady growth.

Key Players in the Market

Leading companies are continuously investing in R&D and technological innovations to maintain their competitive edge. Major players in the urolithiasis management devices market include.
  • Allengers
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare
These companies are focusing on product innovations, strategic partnerships, and global expansion to strengthen their market presence.

Market Segmentation

By Treatment Type:

  • Extracorporeal Shock Wave Lithotripsy (ESWL)
  • Percutaneous Nephrolithotomy
  • Intracorporeal Lithotripsy
  • Others

By Product Type:

  • Lithotripters
  • Ureteroscopes

By End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Urolithiasis Management Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Urolithiasis Management Devices Market Outlook, 2019 - 2032
3.1. Global Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
3.1.1.2. Percutaneous Nephrolithotomy
3.1.1.3. Intracorporeal Lithotripsy
3.1.1.4. Others
3.2. Global Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Lithotripters
3.2.1.2. Ureteroscopes
3.3. Global Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. Hospitals and Clinics
3.3.1.2. Ambulatory Surgical Centers (ASCs)
3.4. Global Urolithiasis Management Devices Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Urolithiasis Management Devices Market Outlook, 2019 - 2032
4.1. North America Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
4.1.1.2. Percutaneous Nephrolithotomy
4.1.1.3. Intracorporeal Lithotripsy
4.1.1.4. Others
4.2. North America Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Lithotripters
4.2.1.2. Ureteroscopes
4.3. North America Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Hospitals and Clinics
4.3.1.2. Ambulatory Surgical Centers (ASCs)
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Urolithiasis Management Devices Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. U.S. Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
4.4.1.2. U.S. Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
4.4.1.3. U.S. Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
4.4.1.4. Canada Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
4.4.1.5. Canada Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
4.4.1.6. Canada Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Urolithiasis Management Devices Market Outlook, 2019 - 2032
5.1. Europe Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
5.1.1.2. Percutaneous Nephrolithotomy
5.1.1.3. Intracorporeal Lithotripsy
5.1.1.4. Others
5.2. Europe Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Lithotripters
5.2.1.2. Ureteroscopes
5.3. Europe Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Hospitals and Clinics
5.3.1.2. Ambulatory Surgical Centers (ASCs)
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Urolithiasis Management Devices Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Germany Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.2. Germany Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.3. Germany Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.4. U.K. Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.5. U.K. Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.6. U.K. Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.7. France Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.8. France Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.9. France Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.10. Italy Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.11. Italy Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.12. Italy Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.13. Turkey Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.14. Turkey Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.15. Turkey Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.16. Russia Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.17. Russia Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.18. Russia Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.1.19. Rest of Europe Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
5.4.1.20. Rest of Europe Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
5.4.1.21. Rest of Europe Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Urolithiasis Management Devices Market Outlook, 2019 - 2032
6.1. Asia Pacific Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
6.1.1.2. Percutaneous Nephrolithotomy
6.1.1.3. Intracorporeal Lithotripsy
6.1.1.4. Others
6.2. Asia Pacific Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Lithotripters
6.2.1.2. Ureteroscopes
6.3. Asia Pacific Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Hospitals and Clinics
6.3.1.2. Ambulatory Surgical Centers (ASCs)
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Urolithiasis Management Devices Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
6.4.1. Key Highlights
6.4.1.1. China Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.2. China Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.3. China Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.4. Japan Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.5. Japan Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.6. Japan Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.7. South Korea Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.8. South Korea Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.9. South Korea Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.10. India Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.11. India Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.12. India Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.13. Southeast Asia Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.14. Southeast Asia Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.15. Southeast Asia Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.1.16. Rest of Asia Pacific Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
6.4.1.17. Rest of Asia Pacific Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
6.4.1.18. Rest of Asia Pacific Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Urolithiasis Management Devices Market Outlook, 2019 - 2032
7.1. Latin America Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
7.1.1.2. Percutaneous Nephrolithotomy
7.1.1.3. Intracorporeal Lithotripsy
7.1.1.4. Others
7.2. Latin America Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
7.2.1.1. Lithotripters
7.2.1.2. Ureteroscopes
7.3. Latin America Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Hospitals and Clinics
7.3.1.2. Ambulatory Surgical Centers (ASCs)
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Urolithiasis Management Devices Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Brazil Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
7.4.1.2. Brazil Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.3. Brazil Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.4. Mexico Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
7.4.1.5. Mexico Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.6. Mexico Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.7. Argentina Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
7.4.1.8. Argentina Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.9. Argentina Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
7.4.1.10. Rest of Latin America Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
7.4.1.11. Rest of Latin America Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
7.4.1.12. Rest of Latin America Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Urolithiasis Management Devices Market Outlook, 2019 - 2032
8.1. Middle East & Africa Urolithiasis Management Devices Market Outlook, by Treatment Type, Value (US$ Bn), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Extracorporeal Shock Wave Lithotripsy (ESWL)
8.1.1.2. Percutaneous Nephrolithotomy
8.1.1.3. Intracorporeal Lithotripsy
8.1.1.4. Others
8.2. Middle East & Africa Urolithiasis Management Devices Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Lithotripters
8.2.1.2. Ureteroscopes
8.3. Middle East & Africa Urolithiasis Management Devices Market Outlook, by End User, Value (US$ Bn), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Hospitals and Clinics
8.3.1.2. Ambulatory Surgical Centers (ASCs)
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Urolithiasis Management Devices Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. GCC Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
8.4.1.2. GCC Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.3. GCC Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.4. South Africa Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
8.4.1.5. South Africa Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.6. South Africa Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.7. Egypt Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
8.4.1.8. Egypt Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.9. Egypt Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.10. Nigeria Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
8.4.1.11. Nigeria Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.12. Nigeria Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
8.4.1.13. Rest of Middle East & Africa Urolithiasis Management Devices Market by Treatment Type, Value (US$ Bn), 2019 - 2032
8.4.1.14. Rest of Middle East & Africa Urolithiasis Management Devices Market by Product Type, Value (US$ Bn), 2019 - 2032
8.4.1.15. Rest of Middle East & Africa Urolithiasis Management Devices Market by End User, Value (US$ Bn), 2019 - 2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs by Product Type Heat map
9.2. Manufacturer vs by Product Type Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Allengers
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Boston Scientific
9.5.3. BD
9.5.4. Cook Medical
9.5.5. ConMed
9.5.6. DirexGroup
9.5.7. Dornier MedTech
9.5.8. KARL STORZ
9.5.9. Potent Optotronic
9.5.10. HealthTronics
9.5.11. Lumenis
9.5.12. Olympus
9.5.13. Richard Wolf
9.5.14. Siemens Healthcare
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Allengers
  • Boston Scientific
  • BD
  • Cook Medical
  • ConMed
  • DirexGroup
  • Dornier MedTech
  • KARL STORZ
  • Potent Optotronic
  • HealthTronics
  • Lumenis
  • Olympus
  • Richard Wolf
  • Siemens Healthcare

Methodology

Loading
LOADING...